Clinical trial
A Multicenter, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
NCT03068754 is registered in ClinicalTrials.gov with Mallinckrodt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in the Treatment of Subjects With Amyotrophic Lateral Sclerosis
- Lead sponsor
- Mallinckrodt
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- June 22, 2017
- Completion date
- November 25, 2019
- Enrollment
- 143 (actual)
- Sites
- 69
Conditions
As the registry lists them; a condition with its own page is linked.